3 Biotech Stocks That Could Be Buyout Targets
Are these biotech stocks on the radar of bigger biotech and pharmaceutical companies? Though there's no way to know for certain, these companies certainly present attractive platforms for a potential acquirer.
Intrexon Energy Partners and Dominion Enter Exclusive Agreement in Marcellus and Utica Basins to Com
Intrexon Energy Partners and Dominion Enter Exclusive Agreement in Marcellus and Utica Basins to Commercialize Novel Method for Natural Gas Bioconversion to Valuable Isobutanol
Why Ziopharm Oncology Shares Were Slammed
Ziopharm Oncology gets taken to the woodshed following the release of its second-quarter earnings results. Find out what went amiss.
Intrexon Second-Quarter Earnings: Rocket-Ship Growth and Acquisitions Continue
The synthetic biology leader set a new watermark for quarterly revenue in the second quarter and made a major acquisition. Here's what investors need to know.